Displaying 1 - 1 of 1
| Active Ingredient | UMECLIDINIUM | VILANTEROL |
| Therapeutic Class | RESPIRATORY AGENTS MISCELLANEOUS |
| Indications | Moderate to severe chronic obstructive pulmonary disease (COPD). |
| Caution | As for Vilanterol/Fluticasone; The inhaler should be discarded 6 weeks after opening. |
| Dose Range | One inhalation once daily at the same time each day . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |